fingolimod has been researched along with tak-441 in 1 studies
| Studies (fingolimod) | Trials (fingolimod) | Recent Studies (post-2010) (fingolimod) | Studies (tak-441) | Trials (tak-441) | Recent Studies (post-2010) (tak-441) |
|---|---|---|---|---|---|
| 65 | 0 | 51 | 10 | 1 | 10 |
| Protein | Taxonomy | fingolimod (IC50) | tak-441 (IC50) |
|---|---|---|---|
| Cytochrome P450 2A6 | Homo sapiens (human) | 0.0044 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.0044 | |
| Sonic hedgehog protein | Mus musculus (house mouse) | 0.0044 | |
| Smoothened homolog | Homo sapiens (human) | 0.079 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadden, MK; Wen, J | 1 |
1 review(s) available for fingolimod and tak-441
| Article | Year |
|---|---|
Medulloblastoma drugs in development: Current leads, trials and drawbacks.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cerebellar Neoplasms; Humans; Medulloblastoma; Protein Kinase Inhibitors | 2021 |